LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Home・Список акций・Vivani Medical

Vivani Medical

Закрыт

1.3

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.3

Макс.

1.3

Ключевые показатели
By Trading Economics
Сотрудники	37

Дивиденды
By Dow Jones
Следующий отчет о доходах	30 мар. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-20M 84M
Предыдущая цена открытия	1.3
Предыдущая цена закрытия	1.3

Vivani Medical График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

22 февр. 2026 г., 23:55 UTC

Обсуждения рынка

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22 февр. 2026 г., 23:53 UTC

Обсуждения рынка

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22 февр. 2026 г., 23:53 UTC

Обсуждения рынка

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22 февр. 2026 г., 23:51 UTC

Обсуждения рынка

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22 февр. 2026 г., 23:35 UTC

Обсуждения рынка

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22 февр. 2026 г., 23:21 UTC

Отчет

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22 февр. 2026 г., 23:20 UTC

Отчет

Nickel Industries 2025 Operating Profit US$126.4 Million

22 февр. 2026 г., 23:19 UTC

Отчет

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22 февр. 2026 г., 23:19 UTC

Отчет

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22 февр. 2026 г., 23:18 UTC

Отчет

Nickel Industries Won't Pay a Final Dividend

22 февр. 2026 г., 23:16 UTC

Отчет

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22 февр. 2026 г., 21:35 UTC

Отчет

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22 февр. 2026 г., 21:34 UTC

Отчет

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22 февр. 2026 г., 21:34 UTC

Отчет

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22 февр. 2026 г., 21:33 UTC

Отчет

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22 февр. 2026 г., 21:33 UTC

Отчет

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22 февр. 2026 г., 21:28 UTC

Отчет

Ampol Final Dividend A$0.60/Share

22 февр. 2026 г., 21:28 UTC

Отчет

Ampol FY Revenue A$31.37 Billion, Down 10%

22 февр. 2026 г., 21:28 UTC

Отчет

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22 февр. 2026 г., 21:28 UTC

Отчет

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21 февр. 2026 г., 14:31 UTC

Приобретения, слияния, поглощения

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21 февр. 2026 г., 05:15 UTC

Обсуждения рынка

Global Commodities Roundup: Market Talk

20 февр. 2026 г., 23:12 UTC

Приобретения, слияния, поглощения

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20 февр. 2026 г., 22:12 UTC

Отчет

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

20 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Auto & Transport Roundup: Market Talk

20 февр. 2026 г., 21:23 UTC

Отчет

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20 февр. 2026 г., 21:20 UTC

Обсуждения рынка

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20 февр. 2026 г., 21:01 UTC

Приобретения, слияния, поглощения

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20 февр. 2026 г., 20:38 UTC

Обсуждения рынка

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Сравнение c конкурентами

Изменение цены

Vivani Medical Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

Покупка

Удержание

Продажа

Основано на мнении 0 аналитиков, присваивавших рейтинги акциям Vivani Medical – Данные за последние 3 месяца.

Финансовые показатели

О компании Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.